Redcliffe Labs has announced a strategic leadership transition. Its Founder, Aditya Kandoi, has stepped in as Chief Executive Officer (CEO), and Dheeraj Jain has taken up the role of Chairman of the Board.
As a CEO, Aditya Kandoi furthers the purposeful vision of Redcliffe Labs which is focussed on Giving every Indian the Right to Quality Diagnostics. Recognizing the critical-care gap in the healthcare sector, he has made it his mission to ensure that timely and accurate diagnostic services are accessible to all. Aditya is introducing a strategic framework based on four key pillars: awareness, affordability, accuracy, and accessibility. By creating awareness campaigns, the company aims to highlight the importance of preventive care and democratize access to high-quality diagnostics to every Indian, especially the underserved population.
Redcliffe Labs, as part of its strategic objective, plans to spur profitable growth with exceptional consumer services, delivering top medical quality and the highest corporate governance. Under Aditya’s leadership, Redcliffe Labs has an ambitious expansion strategy that will extend the company’s reach to Tier 2, Tier 3, Tier 4 cities and beyond so that everyone across the nation has access to quality healthcare services and does not limit to metro & Tier 1 cities only.
Aditya Kandoi, CEO of Redcliffe Labs, said, "At Redcliffe Labs, we are committed to redefining the accessibility of quality healthcare by focusing on innovation, operational excellence, and patient-centric solutions. Our vision goes beyond delivering diagnostics—we aim to empower every individual with the quality diagnostics to take charge of their holistic health and well-being. Together with our highly skilled and self-driven team, we will work tirelessly to bridge the healthcare gap and set new standards in the industry. It is a step towards contributing to a healthier and stronger Bharat.”
In the new position, Dheeraj Jain leads the Board of Directors as Chairman, providing strategic oversight, facilitating governance, and ensuring effective board management. As a Founder & Mentor to the company, he will be crucial in guiding Redcliffe Labs through its next growth phase. Dheeraj is a flag bearer of entrepreneurship, well known for numerous success stories; he continues to support the start-up ecosystem very actively by strategically guiding the budding companies and serves as an inspiration to many entrepreneurs to scale and contribute to India’s super growth story.
Dheeraj Jain, Chairman of Redcliffe Labs, said, “Redcliffe Labs has always been driven by a vision to make healthcare accessible and impactful. After being its CEO for 6 years since its inception, I am delighted to welcome my Co-founder Aditya Kandoi to take charge as its CEO, whose exceptional execution expertise and visionary approach will be instrumental in taking Redcliffe Labs to new heights and setting benchmarks for healthcare standards nationwide & even globally. Together, we will be steering the organization through a phase of transformative growth while upholding our values of innovation and customer excellence. With a passionate leadership team and a shared commitment to delivering top medical quality, we will redefine healthcare standards in India.”
Since its inception in 2018, Redcliffe Labs has grown rapidly to establish itself as one of India's leading omnichannel diagnostics chains. The company operates over 80 state-of-the-art labs, processes tests from over 2,000 collection centers, and offers home collection services powered by a team of 1,000+ phlebotomists across 220+ cities in India. In 2022, Redcliffe Labs completed its Series B fundraising, which fueled remarkable growth and significant expansion of its diagnostic network. The recent Series C funding round further propels its mission to provide India with the right to quality diagnostics while driving innovation and accessibility across the country.
